AHA Action Center
Bringing you essential updates from the American Heart Association (AHA) Scientific Sessions is the AHA Action Center. Here you’ll find in-depth discussions and analyses on the latest research, management guidelines, and innovations in cardiology, directly from leading experts in the field featured at the conference.
1-14 of 14

GLP-1 Receptor Agonists in Stroke Prevention: Evidence of Ischemic Benefit
Clinician's RoundtableGLP-1 Receptor Agonists in Stroke Prevention: Evidence of Ischemic Benefit

Understanding the Growing Impacts of Obesity on Patient Outcomes and Care Delivery
Clinician's RoundtableUnderstanding the Growing Impacts of Obesity on Patient Outcomes and Care Delivery

Targeting Lipoprotein(a): A New Frontier in Heart Disease
Heart MattersTargeting Lipoprotein(a): A New Frontier in Heart Disease

The GRADE Framework: Five Lenses for Evaluating Randomized Trial Evidence
Heart MattersThe GRADE Framework: Five Lenses for Evaluating Randomized Trial Evidence

Treating What We Can: A Practical Approach to High Lipoprotein(a)
Heart MattersTreating What We Can: A Practical Approach to High Lipoprotein(a)

Turning an Lp(a) Result into a Prevention Opportunity
Heart MattersTurning an Lp(a) Result into a Prevention Opportunity
- advertisement

Rethinking CKD Screening in the Era of New Therapies
Heart MattersRethinking CKD Screening in the Era of New Therapies

Who Should Be Tested for Chronic Kidney Disease?
Heart MattersWho Should Be Tested for Chronic Kidney Disease?

Rethinking Hormones: Testosterone and Estrogen in Women’s Heart Health
Heart MattersRethinking Hormones: Testosterone and Estrogen in Women’s Heart Health

Targeting Vascular KCNQ5 Channels: A Promising Strategy for Blood Pressure Control
Heart MattersTargeting Vascular KCNQ5 Channels: A Promising Strategy for Blood Pressure Control

Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control
Heart MattersNavigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control

PREVENT vs PCE: Refining ASCVD Risk Prediction in Statin-Treated Populations
Heart MattersPREVENT vs PCE: Refining ASCVD Risk Prediction in Statin-Treated Populations
- advertisement

The LDL-C Gap in Statin-Treated Patients: A Population-Level Problem with Economic Consequences
Heart MattersThe LDL-C Gap in Statin-Treated Patients: A Population-Level Problem with Economic Consequences

Reframing Monotherapy and Combination Strategies for Hyperlipidemia
Heart MattersReframing Monotherapy and Combination Strategies for Hyperlipidemia























